PIL - Doxycycline Capsules BP 50mg, 100mg: Change history
View Patient Information Leaflet (PIL - Doxycycline Capsules BP 50mg, 100mg)
Last updated on this site: 20 May 2026
Description of update:
To update sections 4.5 and 5.1 of the SmPC in line with the reference product Vibramycin-D 100 mg Dispersible Tablets - PL 00057/0188 (MAH: Pfizer Limited), dated 10/10/2025. Consequently, the PIL has been updated. Additional minor editorial changes made to section 4 of the PIL.
Date of approval: 13/05/2026
PIL sections updated: 2, 4, 5 and 6
Last updated on this site: 20 May 2026
Description of update:
To update sections 4.5 and 5.1 of the SmPC in line with the reference product Vibramycin-D 100 mg Dispersible Tablets - PL 00057/0188 (MAH: Pfizer Limited), dated 10/10/2025. Consequently, the PIL has been updated. Additional minor editorial changes made to section 4 of the PIL.
Date of approval: 13/05/2026
PIL sections updated: 2, 4, 5 and 6
-
Changes: (Updated: 20 May 2026)
Description of update:
To update sections 4.5 and 5.1 of the SmPC in line with the reference product Vibramycin-D 100 mg Dispersible Tablets - PL 00057/0188 (MAH: Pfizer Limited), dated 10/10/2025. Consequently, the PIL has been updated. Additional minor editorial changes made to section 4 of the PIL.
Date of approval: 13/05/2026
PIL sections updated: 2, 4, 5 and 6
-
Changes: (Updated: 08 Apr 2025)
IB C.I.2.a - SmPC section 4.8 for the above-listed MA has been updated in line with the reference product Vibramycin-D 100 mg Dispersible Tablets - PL 00057/0188 (MAH: Pfizer Limited), dated March 2024. Consequently the PIL has been updated. Additionally, editorial updates have been made throughout the PIL.
-
Changes: (Updated: 20 Sep 2022)
Initial upload